Title : A novel NF-kappaB inhibitor DHMEQ selectively targets constitutive NF-kappaB activity and induces apoptosis of multiple myeloma cells in vitro and in vivo.

Pub. Date : 2005 Mar 10

PMID : 15523684






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Compared to other compounds having the potential to inhibit NF-kappaB, DHMEQ is a unique compound that blocks the translocation of NF-kappaB p65 into the nucleus and selectively targets NF-kappaB activated in tumor cells. dehydroxymethylepoxyquinomicin v-rel reticuloendotheliosis viral oncogene homolog A (avian) Mus musculus